生物活性 | |||
---|---|---|---|
描述 | Sincalide is a rapid-acting, synthetic analog of cholecystokinin for intravenous use in postevacuation cholecystography[3]. Sincalide-stimulated cholescintigraphy is performed to quantify gallbladder contraction and emptying[4]. Sincalide antagonized the effect of morphine which inhibited the potentiation of ACh (Acetylcholine) on jejunal activities in vitro. The antagonistic effect of sincalide on morphine was mainly mediated by CCK-A receptor[5]. Sincalide (CCK-8) evoked guinea pig isolated ileum contraction at 10(-5)-10(-1) mumol/L in a concentration-dependent manner, EC50 being 207 pmol/L. It delayed the gastric emptying as well. The rate of inhibition of gastric emptying was 71 +/- 12% at 100 mg/kg by ip[6]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00737295 | Biliary Dyskinesia | Not Applicable | Terminated(PI left institution... 展开 >>, study interest wained-so stopped.) 收起 << | - | United States, Texas ... 展开 >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 收起 << |
NCT01656057 | To Assess the Impact of Bile A... 展开 >>cids on Human Glukagon-like-peptide-1 Secretion 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> University Hospital of Copenhagen, Gentofte Hospital, Diabetic Research Division Copenhagen, Hellerup, Denmark, 2900 收起 << |
NCT02496221 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.87mL 0.17mL 0.09mL |
4.37mL 0.87mL 0.44mL |
8.75mL 1.75mL 0.87mL |
参考文献 |
---|